These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21358463)

  • 21. FACTORS INFLUENCING NEED FOR RETREATMENT AND LONG-TERM VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Ng DS; Kwok AK; Tong JM; Chan CW; Li WW
    Retina; 2015 Dec; 35(12):2457-68. PubMed ID: 26035400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A long-term study of photodynamic therapy with verteporfin for choroidal neovascularization at the edge of chorioretinal atrophy in pathologic myopia.
    Pece A; Milani P; Isola V; Pierro L
    Ophthalmologica; 2011; 225(3):161-8. PubMed ID: 21212705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photodynamic therapy for juxtafoveal choroidal neovascularization in myopic eyes.
    Cohen SY; Bulik A; Dubois L; Quentel G
    Am J Ophthalmol; 2003 Aug; 136(2):371-4. PubMed ID: 12888071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FIVE-YEAR OUTCOMES OF INTRAVITREAL INJECTION OF RANIBIZUMAB FOR THE TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Wu TT; Kung YH
    Retina; 2017 Nov; 37(11):2056-2061. PubMed ID: 28590318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.
    Lam DS; Chan WM; Liu DT; Fan DS; Lai WW; Chong KK
    Br J Ophthalmol; 2004 Oct; 88(10):1315-9. PubMed ID: 15377558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different dosing of intravitreal bevacizumab for choroidal neovascularization because of pathologic myopia.
    Wakabayashi T; Ikuno Y; Gomi F
    Retina; 2011 May; 31(5):880-6. PubMed ID: 21242860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
    Sharp DM; Lai S; Markey CM
    Clin Exp Ophthalmol; 2007; 35(1):24-31. PubMed ID: 17300567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Choroidal neovascularization in pathologic myopia: three-year results after photodynamic therapy.
    Krebs I; Binder S; Stolba U; Glittenberg C; Brannath W; Goll A
    Am J Ophthalmol; 2005 Sep; 140(3):416-25. PubMed ID: 16139000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization.
    Ruiz-Moreno JM; Montero JA; Arias L; Araiz J; Gomez-Ulla F; Silva R; Piñero DP
    Retina; 2010; 30(10):1609-15. PubMed ID: 20856171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.
    Browning AC; Chung AK; Ghanchi F; Harding SP; Musadiq M; Talks SJ; Yang YC; Amoaku WM;
    Ophthalmology; 2005 Jul; 112(7):1227-31. PubMed ID: 15921757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of subfoveal choroidal neovascularization in pathologic myopia with photodynamic therapy: outcomes at 1 and 2 years of follow-up].
    El Matri L; Bouraoui R; Merdassi A; Baccouri R; Mghaieth F; Ben Rejeb S; Meddeb S
    J Fr Ophtalmol; 2006 Sep; 29(7):765-70. PubMed ID: 16988626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined therapy: photodynamic therapy and bevacizumab to treat myopic neovascular membranes. One-year follow-up.
    Desco MC; Mataix J; Garcia-Pous M; Palacios-Pozo E; Navea A
    Retina; 2011 Mar; 31(3):475-81. PubMed ID: 20966825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macular function after PDT in myopic maculopathy: psychophysical and electrophysiological evaluation.
    Varano M; Parisi V; Tedeschi M; Sciamanna M; Gallinaro G; Capaldo N; Catalano S; Pascarella A
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1453-62. PubMed ID: 15790915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series.
    Chan WM; Lam DS; Wong TH; Lai TY; Kwok AK; Tam BS; Li KK
    Ophthalmology; 2003 Dec; 110(12):2395-402. PubMed ID: 14644724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. photodynamic therapy for Taiwanese patients with pathologic myopia: a 2-year follow-up.
    Chen YS; Lin JY; Tseng SY; Yow SG; Hsu WJ; Tsai SC
    Retina; 2007 Sep; 27(7):839-45. PubMed ID: 17891006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bevacizumab for choroidal neovascularization secondary to pathologic myopia: Is there a decline of the treatment efficacy after 2 years?
    Voykov B; Gelisken F; Inhoffen W; Voelker M; Bartz-Schmidt KU; Ziemssen F
    Graefes Arch Clin Exp Ophthalmol; 2010 Apr; 248(4):543-50. PubMed ID: 20111971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.
    Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA; Tewari A
    Retina; 2006; 26(9):988-93. PubMed ID: 17151484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation in pathologic myopia.
    Gelisken F; Inhoffen W; Hermann A; Grisanti S; Bartz-Schmidt KU
    Graefes Arch Clin Exp Ophthalmol; 2004 Nov; 242(11):926-30. PubMed ID: 15258776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.